Yeni arama için tıklayınız.
 

Yayınlanmış Makale

MURAT DİZBAY

Tigecycline: its potential for treatment of brucellosis

Tigecycline: its potential for treatment of brucellosis

İngilizce

Scandinavian Journal of Infectious Diseases

5

39

432-434

2007

http://dx.doi.org/10.1080/00365540601105756

Tigecycline, brucella, combination, synergy, susceptibility

 

The in vitro efficacy and synergistic activity of tigecycline in comparison with other antimicrobials used in brucellosis, were tested for 16 Brucella melitensis strains by the E-test method. Tigecycline had the lowest minimal inhibitory concentration levels and rifampin the highest in the study. Tigecycline also provided the better synergistic activity compared to doxycycline according to the fractional inhibitory concentration index. The results of this in vitro study suggest tigecycline as a therapeutic alternative for brucellosis. These observations need to be supported with clinical studies.

 

The in vitro efficacy and synergistic activity of tigecycline in comparison with other antimicrobials used in brucellosis, were tested for 16 Brucella melitensis strains by the E-test method. Tigecycline had the lowest minimal inhibitory concentration levels and rifampin the highest in the study. Tigecycline also provided the better synergistic activity compared to doxycycline according to the fractional inhibitory concentration index. The results of this in vitro study suggest tigecycline as a therapeutic alternative for brucellosis. These observations need to be supported with clinical studies.